Skip to content

Cash ratio at other companies

Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
-1.8×
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
5.1×+1.5×
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
+3.7×
Precigen logo
PrecigenPGEN
0.4×+0.1×
Zymeworks logo
ZymeworksZYME
6.9×+5.7×
ADMA Biologics logo
ADMA BiologicsADMA
1.9×+0.5×

Other financials

Income statement

See full
Revenue$8.3M+96.3%
Operating income-$57.5M+8.2%
Net income-$43.2M+5.4%
EPS (diluted)-$0.14+6.7%

Balance sheet

See full
Cash & equivalents$102.1M-44.6%
Total debt$140.2M+107%
Total equity$938.1M-8.3%
Total assets$1.3B-2.8%

Cash flow

See full
Operating cash flow-$33.5M-190%
CapEx$3.8M-64.0%
Free cash flow-$37.4M-68.3%

Valuation

See full
Market cap$1.84B+59.2%

Profitability

See full
Operating margin-267.6%-120pp
Net margin-181.7%-77.9pp
FCF margin-238.9%-90.9pp

Returns & leverage

See full
Return on equity-14.7%-0.8pp
Debt / equity0.1×+0.1×
Current ratio14.1×+3.9×

Where this comes from

Calculated from AbCellera Biologics Inc.’s reported figures.

Based on the most recent quarter.

The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbCellera Biologics Inc.'s cash ratio?
AbCellera Biologics Inc. (ABCL) reported cash ratio of 2.2× in Q1 2026.
How has AbCellera Biologics Inc.'s cash ratio changed year-over-year?
AbCellera Biologics Inc.'s cash ratio decreased by 11.7% year-over-year, from 2.4× to 2.2×.
What is the long-term trend for AbCellera Biologics Inc.'s cash ratio?
Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s cash ratio has grown at a -19.0% compound annual growth rate (CAGR), from 5.7× to 2×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.